Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MAN2B2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ACSL5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | AC087350.1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | SSBP3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | SLC39A5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | UBXN2B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | KSR1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | MAPK14 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | RREB1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | EXOC8 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |